GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore Paincare Holdings Ltd (SGX:FRQ) » Definitions » Intrinsic Value: Projected FCF

Singapore Paincare Holdings (SGX:FRQ) Intrinsic Value: Projected FCF : S$0.00 (As of May. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Singapore Paincare Holdings Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-23), Singapore Paincare Holdings's Intrinsic Value: Projected FCF is S$0.00. The stock price of Singapore Paincare Holdings is S$0.153. Therefore, Singapore Paincare Holdings's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Singapore Paincare Holdings's Intrinsic Value: Projected FCF or its related term are showing as below:

SGX:FRQ's Price-to-Projected-FCF is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.295
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Singapore Paincare Holdings Intrinsic Value: Projected FCF Historical Data

The historical data trend for Singapore Paincare Holdings's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore Paincare Holdings Intrinsic Value: Projected FCF Chart

Singapore Paincare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial - - - - -

Singapore Paincare Holdings Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Singapore Paincare Holdings's Intrinsic Value: Projected FCF

For the Medical Care Facilities subindustry, Singapore Paincare Holdings's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Singapore Paincare Holdings's Price-to-Projected-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore Paincare Holdings's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Singapore Paincare Holdings's Price-to-Projected-FCF falls into.



Singapore Paincare Holdings Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Singapore Paincare Holdings  (SGX:FRQ) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Singapore Paincare Holdings's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=0.153/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Singapore Paincare Holdings Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Singapore Paincare Holdings's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Singapore Paincare Holdings (SGX:FRQ) Business Description

Traded in Other Exchanges
N/A
Address
601 Macpherson Road, No. 06-20/21 Grantral Mall, Singapore, SGP, 368242
Singapore Paincare Holdings Ltd is a medical services group engaged in pain care services, and primary care and other services. It offers Pain care services focused on the treatment of patients suffering from chronic pain. Its pain care services include, among others, minimally invasive procedures, cancer pain treatment, specialised injections, pharmacotherapy, and cognitive behavioural therapy. Its Primary care and other services provide general medical consultations, management of chronic and acute conditions, and dermatology services. Through its associated company, it also provides health screening services. The company derives its revenue from Singapore.

Singapore Paincare Holdings (SGX:FRQ) Headlines

No Headlines